University at Buffalo - The State University of New York
Skip to Content

Libido pill's risks have insurers weighing whether to pay

Published August 19, 2015

An article on Bloomberg Business about Addyi, the new drug designed to treat low libido in women, quotes Vanessa Barnabei, director of obstetrics and gynecology at UB. “My guess is that women are going to have to work hard to find providers that are willing to do this,” she said. Articles also appeared in the Indianapolis Business Journal and Chicago Tribune.

Read more:

http://www.bloomberg.com/news/articles/2015-08-19/libido-pill-s-risks-have-insurers-weighing-whether-to-cover-it

http://www.ibj.com/articles/54520-anthem-to-cover-libido-pill-other-insurers-weighing-decision

http://www.chicagotribune.com/news/sns-wp-blm-news-bc-fda-insure19-20150819-story.html

Media Contact Information

Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
Fax: 716-645-3765
ub-news@buffalo.edu